跳至主要内容
临床试验/NCT02384655
NCT02384655Unknown1 期

Effect of Fenugreek Use in Mothers of Preterm on Breast Milk Production and Macronutrient Content

Tel-Aviv Sourasky Medical Center1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2015年3月11日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
入组人数
30
试验地点
1
主要终点
Change in daily volume of expressed milk

研究概览

简要总结

Feeding human milk to preterm infants does reduce the risk of serious and costly neonatal intensive care unit acquired morbidity such as NEC and the late onset sepsis.

It is often difficult to obtain sufficient quantities of human milk from mothers of preterm infants most of whom are breast pump-dependent for weeks or months. Mothers will try to use galactogogues in an attempt to increase milk production. Fenugreek (Trigonella foenum-graecum) seeds is the most commonly used herbal galactogogue and is a member of the pea family. Our experience at the NICU is that around 30% of preterm mothers desperately looking for ways to increase their breast milk supply will eventually took fenugreek (Hilbe) as food supplement. Although widely recommended, there is limited evidence to support the effectiveness of fenugreek as a galactogogue.

The aims of this study are to evaluate whether maternal consumption of fenugreek seeds has any effect on macronutrients composition of breast milk and whether fenugreek is transferred to the infant via mother milk. In addition any changes in mother and infant health status will be assessed.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Healthy mothers 7 to 14 days postpartum,
  • Mothers of preterm infants under 38 weeks of gestation,
  • Mothers with poor milk supply documented by professional lactation consultants.

排除标准

  • Mothers with mastitis,
  • Mothers with breast engorgement,
  • Mothers currently consuming Reglan, Domperidone or other drugs/herbals used to induce milk production,
  • Mothers who are taking medications (Diuretics, Pseudoephedrine, - Anticholinergics, Warfarin or any anticoagulant, An estrogen-containing birth control pill),
  • Mothers with Diabetes mellitus,
  • Mothers who have had breast surgery that could alter milk synthesis or production,
  • Mothers diagnosed with Polycystic Ovary Syndrome,
  • Mothers diagnosed with Asthma or atopic disease,
  • Mothers who are known to be allergic to peanuts or soybeans,
  • Mothers whose milk supply per 24 hours exceeds 600 mL,
  • Mothers with hypo/hyperthyroidism

研究组 & 干预措施

Fenugreek

Experimental

Mothers will take fenugreek for 14 days

干预措施: Fenugreek seed meal (Drug)

结局指标

主要结局

Change in daily volume of expressed milk

时间窗: at day 0, 3, 7, 10, 14

次要结局

  • Change in Macronutrient content analysis of breastmilk(at day 0, 3, 7, 14)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验